CJC-1295 (No DAC) vs MOTS-C: Mechanism, Half-Life & Research Use

Direct Comparison: CJC-1295 (No DAC) vs MOTS-C

In preclinical laboratory settings, evaluating the key differences between CJC-1295 (No DAC) vs MOTS-C requires understanding their distinct biological origins and target pathways. CJC-1295 (No DAC), also known as Modified GRF (1-29), is a 29-amino-acid synthetic peptide designed as a GHRH analog. It acts primarily on the anterior pituitary gland to promote the synthesis and pulsatile release of endogenous growth hormone (GH) and downstream insulin-like growth factor 1 (IGF-1) for tissue repair research.

Conversely, MOTS-C (Mitochondrial Open Reading Frame of the 12S rRNA Type-C) is a 16-amino-acid peptide encoded within the mitochondrial genome. Rather than acting on the somatotropic axis, MOTS-C translocates to the nucleus during metabolic stress to modulate systemic insulin sensitivity, glucose oxidation, and lipid homeostasis. Researchers select between these compounds based on whether their experimental protocol targets neuroendocrine somatotropic signaling or organelle-level metabolic flux.

Labelled Specifications & Comparative Criteria

To assist laboratory researchers in selecting the correct reagent for in vitro or animal models, the following table summarizes the physical, chemical, and experimental properties of both research compounds.

| Criteria | CJC-1295 (No DAC) | MOTS-C | | :--- | :--- | :--- | | **Mechanistic Class** | GHRH Receptor Agonist (Somatotropic Axis) | Mitochondrial-Derived Peptide (MDP) / Metabolic Regulator | | **Primary Target** | Pituitary GHRH Receptor (GHRHR) | AMPK Activation & Nuclear Transcription Factors (e.g., Nrf2) | | **Sequence Length** | 29 Amino Acids | 16 Amino Acids | | **Reported Half-Life** | ~30 minutes (In vivo rodent models) | ~1.5 to 4 hours (In vivo plasma models) | | **Solubility Profile** | Water-soluble; reconstitutes in Sterile Water / BAC Water | Water-soluble; requires gentle agitation in Bacteriostatic Water | | **Typical Preclinical Model**| Rodent models of GH axis dynamics, muscular atrophy, tissue repair | Rodent models of metabolic syndrome, insulin resistance, longevity | | **Available Vial Sizes** | 2 mg, 5 mg | 5 mg, 10 mg |

Laboratory researchers can review our complete catalog of high-purity research peptides to compare full chemical profiles and batch specification data.

Mechanistic Deep Dive: CJC-1295 (No DAC) as a GHRH Analog

CJC-1295 (No DAC) was engineered by substituting four amino acids in the native GHRH (1-29) sequence (Ala2->D-Ala2, Gln8->Gln8, Asp11->Ala11, Leu15->Ala15). These structural modifications enhance chemical stability and confer resistance to enzymatic cleavage by dipeptidyl peptidase-IV (DPP-IV). Studied as a long-acting growth-hormone-releasing hormone that sustains GH and downstream IGF-1 levels for tissue repair research, CJC-1295 (No DAC) retains the physiological pulsatility of GH release without inducing perpetual receptor desensitization.

In vitro assays using rodent pituitary cell cultures demonstrate that binding of CJC-1295 (No DAC) to the GHRH receptor triggers G-protein coupled receptor (GPCR) activation. This increases intracellular cyclic adenosine monophosphate (cAMP) and activates protein kinase A (PKA). The resulting signal cascade stimulates both the transcription of the GH gene and the exocytosis of pre-stored GH vesicles. Because it lacks the Drug Affinity Complex (DAC) maleimide moiety, CJC-1295 (No DAC) does not bind covalently to serum albumin, resulting in a significantly shorter half-life than its DAC-bound counterpart, making it ideal for mimicking natural physiological pulses.

Mechanistic Deep Dive: MOTS-C as a Mitochondrial-Derived Regulator

MOTS-C represents a novel paradigm in molecular biology as a mitochondrial-derived peptide (MDP). Encoded by the mitochondrial 12S rRNA gene, MOTS-C functions as a retrograde signaling molecule. Under physiological baseline conditions, MOTS-C circulates in systemic plasma, but upon exposure to cellular metabolic stress (such as glucose deprivation or oxidative load), it translocates to the cell nucleus.

Preclinical studies suggest that once in the nucleus, MOTS-C interacts directly with transcription factors such as Nrf2 and binds to chromatin to regulate stress-response gene expression. In skeletal muscle rodent models, MOTS-C activation leads to phosphorylation of 5'-AMP-activated protein kinase (AMPK), enhancing glucose uptake independent of insulin receptor signaling. This distinct organelle-to-nucleus axis positions MOTS-C as a specialized reagent for investigating mitochondrial communication, lipid oxidation, and cellular longevity pathways.

Pharmacokinetics, Half-Life, and Stability Profiles

Understanding the pharmacokinetics of these compounds is vital for designing effective dosage intervals in animal models and stability protocols in cell culture media. Preclinical evaluation reveals substantial differences in serum stability, degradation pathways, and active duration.

CJC-1295 (No DAC) exhibits an in vivo plasma half-life of approximately 30 minutes in rodent models. This rapid clearance allows researchers to observe discrete endocrine spikes in circulating growth hormone levels. In contrast, MOTS-C displays a longer plasma half-life ranging from 1.5 to 4 hours, depending on the animal species and metabolic state. MOTS-C clearance is primarily mediated by renal filtration and proteolytic cleavage by non-specific endopeptidases. When storing reconstituted solutions, both compounds require low-temperature maintenance (-20°C to -80°C for long-term storage) to avoid peptide bond hydrolysis.

Metabolic Flux vs. Somatotropic Axis: Experimental Distinctions

When designing comparative bioassays, investigators must evaluate whether their targeted endpoints are driven by somatotropic growth cascades or direct cell-autonomous metabolic pathways. CJC-1295 (No DAC) primary readouts include elevated serum IGF-1 concentration, enhanced nitrogen retention, myofibrillar protein synthesis, and extracellular matrix turnover related to tissue repair.

In contrast, MOTS-C research endpoints focus on intracellular nutrient sensing. Studies measuring oxygen consumption rate (OCR), extracellular acidification rate (ECAR), GLUT4 translocation, and fatty acid oxidation typically utilize MOTS-C. While CJC-1295 (No DAC) indirectly influences systemic metabolism through GH-mediated lipolysis, MOTS-C directly rewires metabolic pathways via AMPK and folates-dependent one-carbon metabolism, making them suitable for complementary yet distinct experimental designs.

Somatotropic and Metabolic Class Comparison

To properly contextualize CJC-1295 (No DAC) within its functional class, researchers frequently compare it against other secretagogues and metabolic modulators. A comprehensive somatotropic research framework often incorporates multiple peptides to assess synergistic or divergent mechanisms.

For instance, researchers exploring maximal GH pulse amplitudes frequently co-administer CJC-1295 (No DAC) with ghrelin receptor agonists like Ipamorelin to evaluate dual-receptor activation (GHRHR and GHSR-1a). Alternatively, investigators studying isolated GHRH pathways may compare CJC-1295 (No DAC) with Tesamorelin, another stabilized GHRH analog with specific structural modifications tailored for lipodystrophy research. When the goal shifts from pituitary stimulation to direct cellular stress signaling, researchers transition from GHRH peptides to mitochondrial peptides like MOTS-C or cellular repair compounds like BPC-157. Insights into these broad mechanistic categories can be explored further in our research library hub.

Study Design Selection: Matching the Compound to Research Objectives

Selecting the appropriate research compound depends entirely on the hypotheses tested within your experimental model. Below is a guide for matching study design objectives with the corresponding compound:

**Choose CJC-1295 (No DAC) if your research protocol targets:** - Pituitary somatotroph response and GH/IGF-1 axis signaling dynamics. - Skeletal muscle hypertrophy, tendon collagen synthesis, or musculoskeletal tissue repair models. - Pulsatile secretagogue signaling without baseline elevation or persistent receptor saturation. **Choose MOTS-C if your research protocol targets:** - Mitochondrial retrograde signaling and nuclear gene expression under metabolic stress. - Insulin resistance models, GLUT4 transporter kinetics, and non-insulin-dependent glucose clearance. - Metabolic longevity, exercise-mimetic pathways, and AMPK kinase activation assays.

For laboratories conducting large-scale high-throughput screening or multi-animal cohort studies, customized batch quantities and dedicated support are accessible via our wholesale laboratory program.

Reconstitution and Laboratory Handling Standards

Achieving consistent bioassay results requires strict adherence to reconstitution and handling protocols for lyophylized research peptides. Standard laboratory procedures dictate that lyophilized vials must reach room temperature prior to reconstitution to prevent moisture condensation within the matrix.

Reconstitution should be performed using sterile Bacteriostatic Water (0.9% benzyl alcohol) or sterile physiological saline depending on the cell culture sensitivity. Reagent water should be directed gently down the glass wall of the vial rather than sprayed directly onto the peptide cake. Gentle swirl mixing is recommended; vortexing must be avoided as mechanical shear stress can disrupt tertiary peptide structure. Researchers calculating volumetric concentrations and diluent volumes should consult our interactive reconstitution calculator for precise lab calculations.

PX1 Research Quality Assurance & Analytical Rigor

PX1 Research is committed to supplying high-purity research reagents manufactured under strict quality standards. Every lot of CJC-1295 (No DAC) and MOTS-C produced for laboratory research use undergoes comprehensive analytical validation in an ISO 17025 accredited laboratory facility.

Our analytical verification protocol includes High-Performance Liquid Chromatography (HPLC) to confirm purity levels exceeding 99%, Mass Spectrometry (MS) to verify precise molecular mass, and chromogenic LAL assays to ensure endotoxin limits remain strictly below regulatory thresholds for laboratory reagents. Researchers can access batch-specific documentation directly via our verified Certificate of Analysis (COA) repository prior to purchase, ensuring full traceability and experimental reproducibility.